Immunosuppressive Drugs Market segment
Biologics are transforming the Immunosuppressive Drugs Market. These drugs, derived from living organisms, target specific pathways in the immune system, offering higher efficacy and fewer side effects compared to traditional medications. Biologics have become essential for patients undergoing organ transplants or dealing with autoimmune disorders.
The emergence of biosimilars has made biologics more affordable, expanding patient access in both developed and developing countries. Pharmaceutical companies are focusing on developing new biologics with better safety profiles and improved patient compliance, which contributes to the overall market growth.
4 Views